subgroup of
drug)
→
ReceivesAction
→
approved
| Typicality: | 0.839 |
| Saliency: | 1.000 |
| between 2000 | 4 | temporal |
| in the us | 2 | location |
| between 2016 | 2 | temporal |
| orphan drug → be → approved | 12 |
| orphan drug → be approved in → the us | 6 |
| orphan drug → be approved by → the fda | 6 |
| negative | neutral | positive |
| 0.090 | 0.642 | 0.267 |
| Raw frequency | 24 |
| Normalized frequency | 1.000 |
| Modifier score | 1.000 |
| Perplexity | 469.555 |